Stocks and InvestingStocks and Investing
Thu, November 3, 2022
Wed, November 2, 2022

Pete Stavropoulos Maintained (ARCT) at Buy with Increased Target to $44 on, Nov 2nd, 2022


Published on 2024-10-27 23:51:43 - WOPRAI, Pete Stavropoulos
  Print publication without navigation


Pete Stavropoulos of Cantor Fitzgerald, Maintained "Arcturus Therapeutics Holdings Inc." (ARCT) at Buy with Increased Target from $39 to $44 on, Nov 2nd, 2022.

Pete has made no other calls on ARCT in the last 4 months.



There are 3 other peers that have a rating on ARCT. Out of the 3 peers that are also analyzing ARCT, 0 agree with Pete's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Pete


  • John Abbott of "Wells Fargo" Maintained at Buy with Decreased Target to $98 on, Wednesday, August 10th, 2022
  • Steven Seedhouse of "Raymond James" Downgraded from Hold to Sell on, Wednesday, August 10th, 2022
  • Pete Stravropoulos of "Cantor Fitzgerald" Initiated at Buy and Held Target at $39 on, Tuesday, July 19th, 2022